Polypharmacy and evaluation of anticholinergic risk in a cohort of elderly people living with HIV.


Journal

AIDS (London, England)
ISSN: 1473-5571
Titre abrégé: AIDS
Pays: England
ID NLM: 8710219

Informations de publication

Date de publication:
01 12 2019
Historique:
entrez: 26 11 2019
pubmed: 26 11 2019
medline: 10 10 2020
Statut: ppublish

Résumé

: As a consequence of ageing, the number of prescribed medications for people living with HIV is increasing. Concomitant use of different drugs and their potential interactions may increase anticholinergic exposure and escalate the risk for side effects. We conducted an analysis in our cohort of people living with HIV over 50 years of age to evaluate the overall anticholinergic risk, as it is useful to identify, prevent, and manage increased side effect risks.

Identifiants

pubmed: 31764110
doi: 10.1097/QAD.0000000000002403
doi:

Substances chimiques

Cholinergic Antagonists 0
Codeine UX6OWY2V7J

Types de publication

Letter Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2439-2441

Auteurs

Maria Mazzitelli (M)

a'Magna Graecia University', Catanzaro, Italy bChelsea and Westminster Hospital NHS Foundation Trust cImperial College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH